ACM
AVDL
Altium Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-419,131
| Closed | -$3.28M | – | 2 |
|
|
2025
Q1 | $3.28M | Sell |
419,131
-33,344
| -7% | -$261K | 7.91% | 4 |
|
|
2024
Q4 | $4.76M | Sell |
452,475
-157,525
| -26% | -$1.66M | 1.35% | 28 |
|
|
2024
Q3 | $8M | Hold |
610,000
| – | – | 2.36% | 14 |
|
|
2024
Q2 | $8.58M | Buy |
610,000
+56,943
| +10% | +$801K | 3.5% | 11 |
|
|
2024
Q1 | $9.34M | Buy |
+553,057
| New | +$9.34M | 3.7% | 6 |
|
|
2023
Q2 | – | Sell |
-500,000
| Closed | -$4.58M | – | 67 |
|
|
2023
Q1 | $4.58M | Buy |
+500,000
| New | +$4.58M | 2.54% | 8 |
|
|
2022
Q1 | – | Sell |
-440,589
| Closed | -$3.56M | – | 119 |
|
|
2021
Q4 | $3.56M | Hold |
440,589
| – | – | 0.98% | 38 |
|
|
2021
Q3 | $4.32M | Hold |
440,589
| – | – | 1.13% | 34 |
|
|
2021
Q2 | $2.97M | Hold |
440,589
| – | – | 0.69% | 60 |
|
|
2021
Q1 | $3.98M | Sell |
440,589
-25,000
| -5% | -$226K | 1.11% | 31 |
|
|
2020
Q4 | $3.11M | Buy |
+465,589
| New | +$3.11M | 1.16% | 35 |
|